These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 34705481)

  • 1. Sepsis-Induced Immunosuppression.
    Torres LK; Pickkers P; van der Poll T
    Annu Rev Physiol; 2022 Feb; 84():157-181. PubMed ID: 34705481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options.
    Liu D; Huang SY; Sun JH; Zhang HC; Cai QL; Gao C; Li L; Cao J; Xu F; Zhou Y; Guan CX; Jin SW; Deng J; Fang XM; Jiang JX; Zeng L
    Mil Med Res; 2022 Oct; 9(1):56. PubMed ID: 36209190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy: A promising approach to reverse sepsis-induced immunosuppression.
    Patil NK; Bohannon JK; Sherwood ER
    Pharmacol Res; 2016 Sep; 111():688-702. PubMed ID: 27468649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Immune Monitoring Approaches for Sepsis-Induced Immunosuppression.
    Yao RQ; Ren C; Zheng LY; Xia ZF; Yao YM
    Front Immunol; 2022; 13():891024. PubMed ID: 35619710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy to treat sepsis induced-immunosuppression: Immune eligibility or outcome criteria, a systematic review.
    Borouchaki A; de Roquetaillade C; Barthélémy R; Mebazaa A; Chousterman BG
    J Crit Care; 2022 Dec; 72():154137. PubMed ID: 36137352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging and Personalized Intervention for Infection and Sepsis.
    Beckmann N; Salyer CE; Crisologo PA; Nomellini V; Caldwell CC
    Surg Infect (Larchmt); 2020 Nov; 21(9):732-744. PubMed ID: 32240042
    [No Abstract]   [Full Text] [Related]  

  • 7. Survival Outcome of Sepsis in Recipients of Solid Organ Transplant.
    Florescu DF; Kalil AC
    Semin Respir Crit Care Med; 2021 Oct; 42(5):717-725. PubMed ID: 34544189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precision Immunotherapy for Sepsis.
    Peters van Ton AM; Kox M; Abdo WF; Pickkers P
    Front Immunol; 2018; 9():1926. PubMed ID: 30233566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balance between Hyperinflammation and Immunosuppression in Sepsis.
    Yadav H; Cartin-Ceba R
    Semin Respir Crit Care Med; 2016 Feb; 37(1):42-50. PubMed ID: 26820273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Research advances of myeloid-derived suppressor cells in sepsis-induced immunosuppression].
    Peng Z; Xu J; He Y; Sun D; Shang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jun; 34(6):666-669. PubMed ID: 35924528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy in sepsis - brake or accelerate?
    Steinhagen F; Schmidt SV; Schewe JC; Peukert K; Klinman DM; Bode C
    Pharmacol Ther; 2020 Apr; 208():107476. PubMed ID: 31931100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-infectious immune suppression: a new paradigm of severe infections.
    Grimaldi D; Llitjos JF; Pène F
    Med Mal Infect; 2014 Oct; 44(10):455-63. PubMed ID: 25169939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in sepsis induced immunosuppression and immunomodulation therapy].
    He X; Bo L; Jiang C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2018 Dec; 30(12):1202-1205. PubMed ID: 30592959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing immune system in sepsis: is individualized immuno-modulatory therapy the answer?
    Boomer JS; Green JM; Hotchkiss RS
    Virulence; 2014 Jan; 5(1):45-56. PubMed ID: 24067565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Immunotherapeutics for Immunosuppression in Sepsis.
    Shin J; Jin M
    Biomol Ther (Seoul); 2017 Nov; 25(6):569-577. PubMed ID: 29081088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy for the adjunctive treatment of sepsis: from immunosuppression to immunostimulation. Time for a paradigm change?
    Leentjens J; Kox M; van der Hoeven JG; Netea MG; Pickkers P
    Am J Respir Crit Care Med; 2013 Jun; 187(12):1287-93. PubMed ID: 23590272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Sepsis-Induced Immunosuppression.
    Venet F; Rimmelé T; Monneret G
    Crit Care Clin; 2018 Jan; 34(1):97-106. PubMed ID: 29149944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy of Sepsis: Blind Alley or Call for Personalized Assessment?
    Prucha M; Zazula R; Russwurm S
    Arch Immunol Ther Exp (Warsz); 2017 Feb; 65(1):37-49. PubMed ID: 27554587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New perspectives on immunomodulatory therapy for bacteraemia and sepsis.
    Opal SM
    Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S70-3. PubMed ID: 21129935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune disorders in sepsis and their treatment as a significant problem of modern intensive care.
    Łysenko L; Leśnik P; Nelke K; Gerber H
    Postepy Hig Med Dosw (Online); 2017 Aug; 71(1):703-712. PubMed ID: 28894043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.